Bristol-Myers sues Merck over U.S. immunotherapy patent
September 05, 2014 at 21:25 PM EDT
Sept 5 (Reuters) - Bristol-Myers Squibb Co on Thursday filed a lawsuit against Merck & Co Inc for allegedly infringing its immunotherapy patent. The company is seeking unspecified damages.
